Asset Management One Co. Ltd. Sells 3,661 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Asset Management One Co. Ltd. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 6.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 51,498 shares of the company’s stock after selling 3,661 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Henry Schein were worth $3,626,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of HSIC. Cromwell Holdings LLC boosted its position in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Versant Capital Management Inc boosted its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares in the last quarter. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares in the last quarter. City State Bank acquired a new stake in shares of Henry Schein in the 4th quarter worth $55,000. Finally, Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of recent analyst reports. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Barrington Research raised their price objective on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Eight investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Stock Performance

Shares of HSIC stock opened at $77.83 on Thursday. The firm has a market capitalization of $9.70 billion, a price-to-earnings ratio of 32.03, a price-to-earnings-growth ratio of 2.15 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business has a fifty day moving average of $74.11 and a 200 day moving average of $72.11. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.